Ticker Details
Equillium, Inc.
IPO Date:	October 8, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$105.95M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 4.83%
Avg Daily Range (30 D):	$0.06 | 4.25%
Avg Daily Range (90 D):	$0.07 | 5.49%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.45M
Avg Daily Volume (90 D):	.59M

Trade Size
Avg Trade Size (Sh.):	300
Avg Trade Size (Sh.) (30 D):	189
Avg Trade Size (Sh.) (90 D):	245

Institutional Trades
Total Institutional Trades:	33
Avg Institutional Trade:	$1.2M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$.91M
Avg Institutional Trade Volume:	.27M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.49M
Avg Closing Trade (30 D):	$.65M
Avg Closing Trade (90 D):	$.65M
Avg Closing Volume:	203.32K

News

Oct 22, 2025 @ 12:00 PM Equillium to Host Ulcerative Colitis KOL Event on ... Source: Equillium, Inc.

Sep 3, 2025 @ 11:30 AM These Were the 5 Top-Performing Stocks in the Nasd... Source: James Brumley

Sep 22, 2024 @ 4:30 AM Graft versus Host Disease Market to Increase at a ... Source: Delveinsight

Sep 16, 2024 @ 1:00 PM Vivtex Enters New Research Agreement w... Source: N/A

May 9, 2024 @ 9:35 PM Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.63	$-.06	$-.16
Diluted EPS	$-.63	$-.06	$-.16
Revenue	$4.39M	$M	$M
Gross Profit
Net Income / Loss	$-24.42M	$-4.23M	$-5.74M
Operating Income / Loss	$-24.37M	$-4.58M	$-6.23M
Cost of Revenue
Net Cash Flow	$17.8M	$21.64M	$-3.03M
PE Ratio